Niagen Bioscience, Inc. cotiza a 2.69 USD y tiene una capitalización bursátil de $213M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Consumo defensivo
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributor…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $0.01 | $0.02 | $0.03 |
| Estimado | $-0.01 | $-0.01 | $0.06 | $0.02 |
| Sorpresa | — | +200.0% | -66.7% | +50.0% |
| Métrica | NAGE | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 64.3% | 30.7% | +33.6% |
| Operating Margin | 12.6% | 1.0% | +11.6% |
| Net Margin | 13.4% | 0.8% | +12.7% |
| FCF Margin | — | 2.4% | — |
| ROE | 22.7% | 5.2% | +17.6% |
| ROA | 16.3% | 0.6% | +15.8% |
| Current Ratio | 4.86 | 1.35 | +3.51 |
| Debt / Equity | — | 0.37 | — |